Intravitreal bevacizumab versus ranibizumab: Effects on the vessels of the fellow non-treated eye
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Current Ophthalmology"
DOI: 10.1016/j.joco.2018.09.007
Abstract: Purpose To evaluate the effects of anti-vascular endothelial growth factors (anti-VEGF) on the vessels of the non-treated eyes following intravitreal injections. Methods In this prospective, non-randomized trial, a total of 38 patients were recruited. 21… read more here.
Keywords: fellow non; treated eyes; injection; intravitreal bevacizumab ... See more keywords
Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.
Sign Up to like & getrecommendations! Published in 2017 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2017.03.057
Abstract: PURPOSE To compare the efficacy and safety of brolucizumab with aflibercept to treat neovascular age-related macular degeneration (AMD). DESIGN Prospective, randomized, double-masked, multicenter, 2-arm, phase 2 study. PARTICIPANTS Eighty-nine treatment-naïve participants, aged ≥50 years, with… read more here.
Keywords: week; brolucizumab; treatment; versus aflibercept ... See more keywords
Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2016-309882
Abstract: Purpose To compare changes in retinal vascular calibre after 2 years of treatment with intravitreal bevacizumab (BVZ) or dexamethasone implant (DEX) in patients with centre-involving diabetic macular oedema (DMO). Methods At baseline, 88 eyes of 61… read more here.
Keywords: retinal vascular; vascular calibre; dex; treated eyes ... See more keywords